| Literature DB >> 35160606 |
Seyyed Mojtaba Mousavi1, Seyyed Alireza Hashemi2, Masoomeh Yari Kalashgrani3, Navid Omidifar4, Sonia Bahrani3, Neralla Vijayakameswara Rao1, Aziz Babapoor5, Ahmad Gholami6, Wei-Hung Chiang1.
Abstract
Today, nanomedicine seeks to develop new polymer composites to overcome current problems in diagnosing and treating common diseases, especially cancer. To achieve this goal, research on polymer composites has expanded so that, in recent years, interdisciplinary collaborations between scientists have been expanding day by day. The synthesis and applications of bioactive GQD-based polymer composites have been investigated in medicine and biomedicine. Bioactive GQD-based polymer composites have a special role as drug delivery carriers. Bioactive GQDs are one of the newcomers to the list of carbon-based nanomaterials. In addition, the antibacterial and anti-diabetic potentials of bioactive GQDs are already known. Due to their highly specific surface properties, π-π aggregation, and hydrophobic interactions, bioactive GQD-based polymer composites have a high drug loading capacity, and, in case of proper correction, can be used as an excellent option for the release of anticancer drugs, gene carriers, biosensors, bioimaging, antibacterial applications, cell culture, and tissue engineering. In this paper, we summarize recent advances in using bioactive GQD-based polymer composites in drug delivery, gene delivery, thermal therapy, thermodynamic therapy, bioimaging, tissue engineering, bioactive GQD synthesis, and GQD green resuscitation, in addition to examining GQD-based polymer composites.Entities:
Keywords: bioactive; biomedical; graphene quantum dots; polymer composites; synthesis
Year: 2022 PMID: 35160606 PMCID: PMC8839953 DOI: 10.3390/polym14030617
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1The applications of bioactive GQD-based polymer composites in biomedicine.
Figure 2The top-down and bottom-up methods for the synthesis of bioactive GQDs.
Different methods for synthesizing bioactive GQDs are used in biomedical applications.
| Synthesis Methods | Application | Size | Ref. |
|---|---|---|---|
|
| |||
| GQD-RhB-silka | Diagnosis | 3–20 nm | [ |
| mango leaf extract—mGQDs | NIR-responsive fluorescence bioimaging | 2–8 nm | [ |
| PEGylated GQD | Fluorescence imaging of tumors | 2.75 nm | [ |
| GQD-PEI | Gene transfection | 3–4 nm | [ |
| GQDs | Drug delivery and bioimaging | ∼12 nm | [ |
| MSN-SS-CD-DOX | Targeted and controlled drugs | 2.7 nm | [ |
|
| |||
| GQD | Diagnosis | 5 nm | [ |
| durian extract—GQDs | Bioimaging | 2–6 nm | [ |
| NP-GQD | Cysteine detection | 10–30 nm | [ |
| GQD-PEG-AG | Radiotherapy | 3–4 nm | [ |
| lignin—GQDs | Bioimaging | 2–6 nm | [ |
Figure 3Synthesis of photoluminescence GQDs by using hydrothermal method from material A.
Figure 4The purification of GQDs using microwave irradiation.
Figure 5The synthesis method of electrochemical oxidation.
Figure 6The ultrasonic synthesis method.
The application of bioactive GQDs in the field of drug delivery.
| Composite | Application | Ref. | |
|---|---|---|---|
| 1 | GQD/DOX | In vitro: A549 cells | [ |
| 2 | SiRNA/GQD/DOX | Therapy of A549 cancer cells | [ |
| 3 | GQD/DOX | In vitro: HeLa, A549, and HEK293A cells | [ |
| 4 | CMC/GQDDOX | Therapy of K562Leukemia cells | [ |
| 5 | GQD/DOX | In vivo: BALB/c mice | [ |
| 6 | GQD/CDDP | Breast cancer cells | [ |
Figure 7Treatment of cancer cells with drug delivery method based on bioactive GQDs.
Figure 8Treatment of cancer cells with gene therapy based on bioactive GQDs.
Figure 9Tumor treatment with the PTT method based on bioactive GQDs.
Figure 10Tumor destruction using the photodynamic method based on bioactive GQDs.
Figure 11Diagnosis of cancer using bioimaging based on bioactive GQD.
Figure 12The important role of bioactive GQDs in damaged bone formation in tissue engineering.